2017 (иностранная)

Logo1

Rytkin E., Mirzaev K.B., Smirnov V.V., et al. Assessment of CYP2C19, ABCB1, CYP3A5 Genes Polymorphisms’ and CYP3A4 Isoenzyme Activity Influence on Major Adverse Cardiovascular Events Among Pat ients with an Acute Coronary Sy ndrome Undergoing Percutaneou
Zastrozhin MS, Brodyansky VM, Skryabin VY, et al. Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder. Pharmgenomics Pers Med. 2017;10:209-215.
Denisenko NP, Sychev DA, Sizova ZM et al. Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients. Pharmacogenomics and Personalized Medicine 2017, 10:253-259
Mirzaev KB, Sychev DA, Ryzhikova KA et al. Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan. Genetic testing and molecular biomarkers. 2017,12:1-7
Mirzaev KB, Zelenskaya EM, Barbarash OL et al. CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndromePharmgenomics Pers Med. 2017;10:107-114.
Rytkin E, Mirzaev KB, Grishina EA et al. Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? Pharmacogenomics and Personalized Medicine 2017, 10:243-245.
Sychev DA, Rozhkov AV, Ananichuk AV et al. Evaluation of genotype-guided acenocoumarol dosing algorithms in Russian patients. Drug Metabol Pers Ther 2017; aop.
Sychev DA, Shuev GN, Suleymanov SS, et al. Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations. Pharmgenomics Pers Med. 2017;10:93-99.
Sychev DA, Zastrozhin MS, Miroshnichenko II et al. Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration. Drug Metab Pers Ther. 2017
Zastrozhin MS, Grishina EA, Ryzhikova KA, et al. The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction. Pharmacogenomics and Personalized Medicine 2018,11:1—5.
Публикации членов общества на иностранном языке